Company

COUR Pharma

Pharmaceutical Manufacturing Skokie, Illinois, United States 80 employees

Employees: 80
Contacts: 3
Emails: 3
Phones: 2

courpharma.com LinkedIn

COUR Pharma Overview

Headquarters: Skokie, Illinois, United States
Website: courpharma.com
Industry: Pharmaceutical Manufacturing
Employees: 80
Founded: 2015
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Pharmaceuticals Immunology Nanomedicine Immune Tolerance Inflammation Nanotechnology

About COUR Pharma

COUR is a clinical-stage biotechnology company working to reprogram the immune system to restore health in people suffering from autoimmune diseases. Using our proprietary COUR nanoparticle (CNP) platform for antigen-specific immune tolerance, we develop first-in-class disease-modifying therapies that target disease at its root—without suppressing normal immune system function. With programs in primary biliary cholangitis (PBC), type 1 diabetes (T1D), myasthenia gravis (MG), and celiac disease, COUR is advancing a new standard for immune-modifying therapies.

COUR Pharma Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

COUR Pharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dannielle Appelhans		Greater Chicago Area, United States	Email
Melanie Mcgill	Director of Technical Development	Greater Chicago Area, United States	Email Phone
Simon Greenwood	Vice President, Venture Investing	South San Francisco, California, United States	Email Phone
Tim Walbert	Former Chairman, President and CEO	Park Ridge, Illinois, United States	View